Mayne Pharma | MYX - Sales Revenues

Stock Price
2.28
Daily Change
-0.04 -1.72%
Monthly
-9.16%
Yearly
-49.89%
Q2 Forecast
2.27

Mayne Pharma reported AUD212.07M in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Ansell USD 1.03B 192.2M Dec/2025
Avita Medical AUD 17.61M 805K Dec/2025
Cochlear AUD 1.18B 590.35M Dec/2025
CSL USD 8.33B 4.79B Dec/2025
Healius AUD 688.1M 245.8M Dec/2025
Integral Diagnostics AUD 238.44M 7.19M Jun/2024
Medical Developments International AUD 21.57M 12.04M Dec/2025
Nanosonics AUD 102.23M 2.8M Dec/2025
Polynovo AUD 70.33M 35.75M Dec/2025
Ramsay Health Care AUD 9.34B 82.2M Dec/2025
ResMed USD 1.42B 87.23M Dec/2025
Sigma Healthcare AUD 1.68B 188.65M Dec/2024
Sonic Healthcare AUD 5.45B 470M Dec/2025
Telix Pharmaceuticals AUD 413.44M 103.71M Dec/2025